A Phase 2 Open-Label Study of EN3835 In The Treatment of Edematous Fibrosclerotic Panniculopathy
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 13 Apr 2018
At a glance
- Drugs Collagenase clostridium histolyticum (Primary)
- Indications Cellulite
- Focus Therapeutic Use
- Sponsors Endo Pharmaceuticals
- 10 Apr 2018 Status changed from recruiting to active, no longer recruiting.
- 16 Nov 2017 Status changed from not yet recruiting to recruiting.
- 09 Nov 2017 New trial record